Authors:
Dooley, WC
Ljung, BM
Veronesi, U
Cazzaniga, M
Elledge, RM
O'Shaughnessy, JA
Kuerer, HM
Hung, DT
Khan, SA
Phillips, RF
Ganz, PA
Euhus, DM
Esserman, LJ
Haffty, BG
King, BL
Kelley, MC
Anderson, MM
Schmit, PJ
Clark, RR
Kass, FC
Anderson, BO
Troyan, SL
Arias, RD
Quiring, JN
Love, SM
Page, DL
King, EB
Citation: Wc. Dooley et al., Ductal lavage for detection of cellular atypia in women at high risk for breast cancer, J NAT CANC, 93(21), 2001, pp. 1624-1632
Authors:
Turner, BC
Krajewski, S
Krajewska, M
Takayama, S
Gumbs, AA
Carter, D
Rebbeck, TR
Haffty, BG
Reed, JC
Citation: Bc. Turner et al., BAG-1: A novel biomarker predicting long-term survival in early-stage breast cancer, J CL ONCOL, 19(4), 2001, pp. 992-1000
Citation: Bd. Smith et al., Molecular markers in head and neck squamous cell carcinoma: Their biological function and prognostic significance, ANN OTOL RH, 110(3), 2001, pp. 221-228
Citation: E. Obedian et Bg. Haffty, Negative margin status improves local control in conservatively managed breast cancer patients, CA J SCI AM, 6(1), 2000, pp. 28-33
Citation: E. Obedian et al., Second malignancies after treatment of early-stage breast cancer: Lumpectomy and radiation therapy versus mastectomy, J CL ONCOL, 18(12), 2000, pp. 2406-2412
Citation: Bd. Smith et al., Prognostic significance of vascular endothelial growth factor protein levels in oral and oropharyngeal squamous cell carcinoma, J CL ONCOL, 18(10), 2000, pp. 2046-2052
Authors:
Smith, TE
Lee, D
Turner, BC
Carter, D
Haffty, BG
Citation: Te. Smith et al., True recurrence vs. new primary ipsilateral breast tumor relapse: An analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management, INT J RAD O, 48(5), 2000, pp. 1281-1289
Authors:
Turner, BC
Gumbs, AA
Carter, D
Glazer, PM
Haffty, BG
Citation: Bc. Turner et al., Cyclin D1 expression and early breast cancer recurrence following lumpectomy and radiation, INT J RAD O, 47(5), 2000, pp. 1169-1176
Citation: E. Obedian et Bg. Haffty, Breast conserving therapy in breast cancer patients presenting with nippledischarge, INT J RAD O, 47(1), 2000, pp. 137-142
Authors:
Yoo, SS
Carter, D
Turner, BC
Sasaki, CT
Son, YH
Wilson, LD
Glazer, PM
Haffty, BG
Citation: Ss. Yoo et al., Prognostic significance of cyclin D1 protein levels in early-stage larynx cancer treated with primary radiation, INT J CANC, 90(1), 2000, pp. 22-28
Authors:
Lehman, TA
Haffty, BG
Carbone, CJ
Bishop, LR
Gumbs, AA
Krishnan, S
Shields, PG
Modali, R
Turner, BC
Citation: Ta. Lehman et al., Elevated frequency and functional activity of a specific germ-line p53 intron mutation in familial breast cancer, CANCER RES, 60(4), 2000, pp. 1062-1069
Authors:
Turner, BC
Gumbs, AA
Carbone, CJ
Carter, D
Glazer, PM
Haffty, BG
Citation: Bc. Turner et al., Mutant p53 protein overexpression in women with ipsilateral breast tumor recurrence following lumpectomy and radiation therapy, CANCER, 88(5), 2000, pp. 1091-1098
Citation: Bg. Haffty et al., Radiation therapy with hyperbaric oxygen at 4 atmospheres pressure in the management of squamous cell carcinoma of the head and neck: Results of a randomized clinical trial, CA J SCI AM, 5(6), 1999, pp. 341-347
Authors:
Burtness, B
Windsor, S
Holston, B
DiStasio, S
Staugaard-Hahn, C
Abrantes, J
Kneuper-Hall, R
Farber, L
Orell, J
Bober-Sorcinelli, K
Haffty, BG
Reiss, M
Citation: B. Burtness et al., Adjuvant sequential dose-dense doxorubicin, paclitaxel, and cyclophosphamide (ATC) for high-risk breast cancer is feasible in the community setting, CA J SCI AM, 5(4), 1999, pp. 224-229
Citation: Bg. Haffty, Who's on first? Sequencing chemotherapy and radiation therapy in conservatively managed node-negative breast, CA J SCI AM, 5(3), 1999, pp. 147-149
Citation: Bd. Smith et Bg. Haffty, Molecular markers as prognostic factors for local recurrence and radioresistance in head and neck squamous cell carcinoma, RADIAT ON I, 7(3), 1999, pp. 125-144
Authors:
Turner, BC
Harrold, E
Matloff, E
Smith, T
Gumbs, AA
Beinfield, M
Ward, B
Skolnick, M
Glazer, PM
Thomas, A
Haffty, BG
Citation: Bc. Turner et al., BRCA1/BRCA2 germline mutations in locally recurrent breast cancer patientsafter lumpectomy and radiation therapy: Implications for breast-conservingmanagement in patients with BRCA1/BRCA2 mutations, J CL ONCOL, 17(10), 1999, pp. 3017-3024
Citation: Bg. Haffty et al., Carcinoma of the larynx treated with hypofractionated radiation and hyperbaric oxygen: Long-term tumor control and complications, INT J RAD O, 45(1), 1999, pp. 13-20